Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Viking Therapeutics Inc (VKTX)

426 + Investors. Track Smart Money conviction in VKTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +21
Streak
1Q ▲
Buyers last Q
54%

Smart Money Signals — VKTX

Based on 435 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added VKTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
435 hedge funds hold VKTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +11% more funds vs a year ago

fund count last 6Q
+43 new funds entered over the past year (+11% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

228 buying197 selling
Last quarter: 228 funds bought or added vs 197 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+12 vs last Q)

new funds entering per quarter
Funds opening a new VKTX position: 47 → 112 → 67 → 79. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

46% of holders stayed for 2+ years

■ 46% conviction (2yr+) ■ 32% medium ■ 22% new
198 out of 435 hedge funds have held VKTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +24% but shares only +7% — price-driven

Value
+23%
Shares
+6%
Last quarter: the total dollar value of institutional holdings rose +24%, but actual share count only changed +7%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~79 new funds/quarter

82 → 47 → 112 → 67 → 79 new funds/Q
New funds entering each quarter: 47 → 112 → 67 → 79. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 53% veterans vs 26% newcomers

■ 53% veterans ■ 21% 1-2yr ■ 26% new
Entry-cohort mix of 466 holders: 245 (53%) are 2+ year veterans, 100 entered 1–2 years ago, and 121 (26%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 62% AUM from top-100 funds

62% from top-100 AUM funds
54 of 430 holders are among the 100 largest funds by AUM, controlling 62% of total institutional value in VKTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — VKTX

In 2026 Q2, 228 hedge funds were net buyers of VKTX (79 opened a new position, 149 added to an existing one), while 197 reduced or exited (139 trimmed, 58 sold completely) — a 54% buyer ratio, indicating a slight buying edge. 62% of total institutional value in VKTX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +21 funds (more new holders than closures). Total institutional holders: 435.

Hedge Fund Ownership: VKTX

How many hedge funds hold VKTX — quarterly history vs. share price
Quarterly hedge fund ownership of VKTX vs. share price

Market Analysis: VKTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: VKTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Viking Therapeutics Inc (VKTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much VKTX has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 81d ago
VKTX
-25.7%
XLV
+6.1%

VKTX outperformed XLV by -31.8% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 36d ago
VKTX
-12.7%
XLV
+0.6%

Since the filing became public, VKTX outperformed XLV by -13.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

16 top-rated funds 3 high-conviction
Consensus
5.3
/ 10
breadth
×
Elite
2.5
/ 10
conviction
Hedge Fund Positioning: VKTX
426 + Investors

Track Smart Money conviction in VKTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 426 414 2.9%
13F Shares 85M 85M 0.92%
Total Value $3.31B $2.78B 19.12%
New Positions 78 67 +11
Increased Positions 142 154 -12
Closed Positions 61 82 -21
Reduced Positions 128 120 +8
Total Calls 24 19 26.32%
Total Puts 11 10 10.0%
PUT/CALL Ratio 0.46 0.53 Bullish

Statistics: VKTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

426 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in VKTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 VKTX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Diadema Partners LP 6.02% 1,220,800 $47.6M
2 Act Capital Management, LLC 5.33% 209,300 $8.2M
3 First Washington CORP 3.56% 381,300 $14.9M
4 Timothy G. Youngquist 2020 Irrevocable Trust 2.90% 112,500 $4.0M
5 Mh & Associates Securities Management Corp /Adv 2.28% 65,180 $2.5M
6 Diadema Partners LP 2.18% 441,808 $17.2M
7 BlackBarn Capital Partners LP 1.97% 600,000 $23.4M
8 Diadema Partners LP 1.73% 350,500 $13.7M
9 Persistent Asset Partners Ltd 1.31% 112,736 $4.4M
10 Artia Global Partners LP 1.30% 180,731 $7.1M
11 Eversept Partners, LP 1.22% 602,922 $23.5M
12 Exome Asset Management LLC 1.15% 47,861 $1.9M
13 ADAR1 Capital Management, LLC 1.02% 574,038 $22.4M
14 Quantum Private Wealth, LLC 0.98% 98,365 $3.8M
15 Lewis Asset Management, LLC 0.91% 66,790 $2.6M
16 Tang Capital Management LLC 0.89% 500,000 $19.5M
17 PFM Health Sciences, LP 0.85% 255,330 $10.0M
18 BlackBarn Capital Partners LP 0.82% 250,000 $9.8M
19 1492 Capital Management LLC 0.64% 55,723 $2.2M
20 Vestal Point Capital, LP 0.62% 680,000 $26.5M
21 Monimus Capital Management, LP 0.60% 66,502 $2.6M
22 MN Wealth Advisors, LLC 0.52% 31,082 $1.2M
23 Odyssean, LLC 0.48% 74,987 $2.9M
24 Rhenman & Partners Asset Management AB 0.47% 128,000 $5.0M
25 Scientech Research LLC 0.46% 14,456 $564K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Viking Therapeutics Inc (VKTX)

What does the Smart Money Trend signal show for VKTX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added VKTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for VKTX?

Slight buying edge — 54% buying: Last quarter: 228 funds bought or added vs 197 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for VKTX holders?

Elite ownership — 62% AUM from top-100 funds: 54 of 430 holders are among the 100 largest funds by AUM, controlling 62% of total institutional value in VKTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held VKTX?

46% of holders stayed for 2+ years: 198 out of 435 hedge funds have held VKTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Viking Therapeutics Inc (VKTX) following the 2026 Q2 hedge fund 13F filings?

As of today, VKTX has moved -12.7% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.6% for the XLV sector ETF — an outperformance of -13.3%. Since the quarter end (June 30, 2026), VKTX has gained -25.7% vs +6.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →